Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

RSPH vs. FHLC: which is better?

Bottom line

RSPH vs FHLC: the short answer

RSPH (Invesco S&P 500 Equal Weight Health Care ETF) and FHLC (Fidelity MSCI Health Care Index ETF) are both etfs.

But FHLC is far broader, holding 337 positions to 63 for RSPH, so beyond the top names it adds exposure RSPH doesn't have.

FHLC is cheaper at 0.084% vs 0.4% — a difference of $32 a year per $10,000 invested.

Over five years, FHLC returned +7.2% a year vs +4.7% for RSPH (reporting dates differ).

Updated Nov 19, 2026

RSPH vs FHLC side by side

RSPHFHLC
TypeETFETF
Fund familyInvescoFidelity
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.4%0.084%
Annual cost per $10k$40$8.4
10-yr cost on $10k (prospectus)$505$108
Max front loadNoneNone
12b-1 fee—0%
1-yr return+9.3%+2.6%
5-yr return (annualized)+4.7%+7.2%
10-yr return (annualized)+8.2%+8.8%
Best quarter+17.5%+16.4%
Worst quarter−14.3%−13.1%
Net assets (fund)$766.9M$3.3B
Number of holdings63337
Portfolio turnover24%3%
Returns as ofDec 31, 2025Nov 30, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearRSPHFHLCDifference
2024−0.8%+2.6%−3.4%
2023+3.9%+2.5%+1.5%
2022−9.2%−5.5%−3.8%
2021+23.0%+20.4%+2.7%
2020+18.9%+18.1%+0.8%
2019+25.3%+21.9%+3.4%
2018−0.3%+5.5%−5.8%
2017+23.4%+23.3%+0.1%
2016−4.5%−3.3%−1.2%
2015+8.2%+7.0%+1.2%

Source: Fund prospectus bar charts

Holdings overlap

7 of RSPH's top 25 holdings also appear in FHLC's top 25.

Shared top holdings
HoldingRSPHFHLC
Regeneron Pharmaceuticals, Inc.1.96%1.15%
Thermo Fisher Scientific Inc.1.84%3.09%
Abbott Laboratories1.83%2.66%
Bristol-Myers Squibb Co.1.82%1.93%
Amgen Inc.1.77%3.00%
AbbVie Inc.1.73%6.42%
Cencora, Inc.1.71%0.83%

Source: SEC Form N-PORT

RSPH top 10

  1. Bio-Techne Corp. — 2.13%
  2. IQVIA Holdings Inc. — 2.00%
  3. Baxter International Inc. — 1.99%
  4. Regeneron Pharmaceuticals, Inc. — 1.96%
  5. Mettler-Toledo International Inc. — 1.94%
  6. Charles River Laboratories International, Inc. — 1.93%
  7. Veeva Systems Inc. — 1.93%
  8. DaVita Inc. — 1.87%
  9. Moderna, Inc. — 1.85%
  10. Thermo Fisher Scientific Inc. — 1.84%

FHLC top 10

  1. Eli Lilly & Co — 13.35%
  2. Johnson & Johnson — 8.93%
  3. AbbVie Inc — 6.42%
  4. UnitedHealth Group Inc — 5.44%
  5. Merck & Co Inc — 4.66%
  6. Thermo Fisher Scientific Inc — 3.09%
  7. Amgen Inc — 3.00%
  8. Abbott Laboratories — 2.66%
  9. Gilead Sciences Inc — 2.34%
  10. Pfizer Inc — 2.06%

FAQ

What is the difference between RSPH and FHLC?
RSPH (Invesco S&P 500 Equal Weight Health Care ETF) and FHLC (Fidelity MSCI Health Care Index ETF) are both etfs. But FHLC is far broader, holding 337 positions to 63 for RSPH, so beyond the top names it adds exposure RSPH doesn't have.
Which is cheaper, RSPH or FHLC?
FHLC has the lower expense ratio (0.084%).
Should I own both RSPH and FHLC?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.